Overview of Stemetil MD

Quick Facts

Property	Description
Active Ingredient	Prochlorperazine Maleate
Form	Mouth Dissolving Tablet (MD)
Pharmacological Class	Phenothiazine Antipsychotic, Antiemetic Agent
Origin	Synthetic

What Type of Medicine is Stemetil MD?

Stemetil MD is a prescription medicine containing the active ingredient Prochlorperazine, a synthetic compound that belongs to the major chemical class of phenothiazines. This medicine holds a dual pharmacological classification, being recognized as both a first-generation (typical) antipsychotic agent and a potent antiemetic agent for controlling severe sickness.

Prochlorperazine is identified as a piperazine phenothiazine derivative. This dual function is clinically recognized, with the medication being a tool for quickly alleviating persistent nausea and vomiting, such as that caused by chemotherapy or migraine.

Composition and Significance of the MD Form

The "MD" in Stemetil MD specifies the dosage form as a Mouth Dissolving Tablet, a unique feature that differentiates the brand from standard tablets which must be swallowed whole. This composition allows for prompt dissolution and absorption via the oral or buccal mucosa, offering a rapid administration route that is particularly beneficial during acute episodes of active vomiting or dizziness.

As a single-active-ingredient product, Stemetil MD contains only Prochlorperazine (typically as the maleate salt). This specific mouth-dissolving format is strategically positioned for the adult patient group needing fast relief from intense nausea or vertigo, contrasting with other available forms like standard tablets, suppositories, and injectable solutions.

General Purpose and Fundamental Action

the medicine's general purpose is driven by its core function as a dopamine D2-receptor antagonist, which translates to a central therapeutic benefit of controlling severe nausea and vomiting. By blocking the effects of the chemical messenger dopamine in specific pathways, Prochlorperazine is uniquely positioned to suppress the central triggers for emesis. This includes the control of severe nausea and vomiting as an approved use for Prochlorperazine.

This fundamental action also provides the stabilizing effects utilized in the short-term management of manifestations of certain psychotic disorders, such as managing agitation or disordered thought patterns.

What side effects are possible with Stemetil MD?

Possible Side Effects and Safety Information

The safety profile of Prochlorperazine, the active ingredient in Stemetil MD, is defined by adverse reactions categorized by their frequency and the physiological systems affected, as documented in official regulatory labeling. These classifications establish the recognized risks associated with the medicine.

Regulatory Classification of Adverse Reactions

Side effects are officially classified into frequency categories, ranging from Common to Rare or Very Rare, aligning with international regulatory standards.

Classification	Examples of Officially Documented Adverse Reactions
Common	Sedation, drowsiness, dry mouth, constipation, blurred vision.
Uncommon	Extrapyramidal symptoms, postural hypotension, skin reactions, ECG changes.
Rare	Jaundice, blood dyscrasias (e.g., agranulocytosis).

Adverse effects are documented across multiple System-Organ Classes, including the Nervous System (e.g., extrapyramidal reactions) and Cardiovascular System (e.g., hypotension).

Serious Safety Considerations and Contextual Notes

Official labeling highlights several serious adverse reactions, including Neuroleptic Malignant Syndrome (NMS) and Tardive Dyskinesia, which involves involuntary, potentially irreversible movements that risk increases with long-term exposure. Venous Thromboembolism and certain cardiac concerns, such as QTc prolongation, are also officially noted.

Population-Specific Safety: A critical constraint is documented for older adults with dementia-related psychosis, who have an officially recognized increased risk of death and stroke when using this class of medication. Furthermore, acute extrapyramidal symptoms are often observed early in treatment or during dose escalation.

Overdose and Emergency Response

Overdose Manifestations and Severe Risks

Overdose involving Prochlorperazine Maleate is documented in regulatory sources as potentially severe, with documented effects on the central nervous system (CNS), cardiovascular system, and autonomic functions. Clinical manifestations primarily include significant CNS depression, ranging from profound drowsiness and disorientation to coma. Severe extrapyramidal symptoms, such as acute dystonias, muscle spasms, and tremor, are expected presentations.

Life-threatening outcomes officially listed include severe hypotension (low blood pressure), dangerous cardiac rhythm disturbances (tachycardia, irregular heartbeat), and apnea. Extrapyramidal muscle rigidity may critically compromise the airway. The elderly and children are noted as populations requiring caution, particularly due to an increased risk of drug-induced Parkinsonism.

Required Emergency Action

Due to the documented potential for life-threatening complications, patients or caregivers must seek immediate medical attention and contact emergency services or Poison Control immediately upon suspected overdose. The official regulatory profile confirms that no specific antidote is known, meaning treatment is strictly supportive and symptomatic, focusing on establishing a clear airway, controlling convulsions (e.g., with i.v. diazepam), and managing severe hypotension with specific agents.

Therapeutic Uses of Stemetil MD

What Stemetil MD Treats: Main Uses and Benefits

Stemetil MD is relevant for symptomatic relief and support in clinical contexts marked by heightened, difficult-to-tolerate symptoms. It is applied across domains where additional symptomatic support is appropriate to help maintain a sense of stability when symptoms become noticeable and disrupt functional stability.

Primary Therapeutic Applications

The medication is applied in addressing distinct therapeutic areas, including its common use for managing severe nausea and vomiting, offering support for vertigo and disorientation relevant in conditions that include Ménière's disease, and providing short-term management of acute manifestations of certain psychotic disorders. The medication is considered relevant for these conditions presenting with systemic or localized discomfort.

In clinical settings marked by heightened patient distress, this medicine may assist with symptomatic relief, supporting the patient during difficult episodes by easing distress. For instance, it is commonly used to help with intense nausea associated with chemotherapy treatments or migraine attacks. For those experiencing vertigo, it supports comfort during periods of heightened symptoms, which may assist with functional stability. For acute manifestations like agitation or disordered thought patterns, the medicine contributes to easing the impact of these challenging manifestations on temporary functional strain.

Quick Fact: Relief for Acute Discomfort
Relief Focus	Symptoms related to severe nausea, vomiting, and vertigo
Type of Support	Symptomatic relief and functional stability
Typical Context	Acute or episodic symptom intensification
Patient Benefit	Supports the patient during difficult, disruptive episodes

Regulatory References

NIH MedlinePlus overview on Prochlorperazine

Eligibility and Restrictions for Use

The eligibility for using Stemetil MD (prochlorperazine) is strictly defined by regulatory documents, which establish Absolute Contraindications and restrictions based on age, physiological state, and co-existing medical conditions.

Contraindications and Exclusion

Stemetil MD is contraindicated and must not be used by patients with:

Known hypersensitivity to prochlorperazine or any other phenothiazine derivative.
Severe central nervous system (CNS) depression, such as comatose states.
Existing conditions like blood dyscrasias, bone marrow depression, phaeochromocytoma, or severe liver impairment.
Children under 2 years of age or weighing less than 20 lbs (approx. 9 kg).

Age- and Condition-Specific Restrictions

Population Group	Regulatory Eligibility Status
Older Adults	Use requires caution and a lower initial dose. It is not approved for the treatment of dementia-related psychosis.
Pediatric Patients	Contraindicated under age 2; use is restricted in children with symptoms suggesting Reye's syndrome.
Cardiovascular/Renal	Use requires caution in patients with severe cardiac disorders or impaired renal function.
Pregnancy/Lactation	Generally avoided during pregnancy unless essential, with particular risk to neonates if used in the third trimester. Not recommended during breastfeeding.

These official statements ensure that the medicine is reserved for eligible populations, limiting use in individuals where systemic or organ function risks are documented.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Prochlorperazine, the active ingredient in Stemetil MD, has documented interaction patterns based on regulatory prescribing information, classified by their effects on the body's processes (pharmacodynamic) and the medicine’s concentration (pharmacokinetic).

Contraindicated Combinations and Intensified Effects

CNS Depressants: Co-administration with central nervous system (CNS) depressants, including alcohol, narcotics, sedatives, and hypnotics, may intensify or prolong their depressant action. Use is formally contraindicated in patients with large amounts of CNS depressants present, such as in a comatose state.
Anticholinergic Agents: The effects of atropine-like drugs and other anticholinergic agents may be potentiated, increasing the specific risk of adverse outcomes like severe constipation or paralytic ileus.
Cardiovascular Risk: The official documentation notes increased risk of QTc interval prolongation and cardiac arrhythmias when Prochlorperazine is co-administered with other QTc-prolonging agents (e.g., quinidine, pimozide).

Exposure-Altering Interactions

Food: Taking this medicine with food is officially documented to decrease the rate and extent of absorption, leading to a measurable reduction in maximum plasma concentration (Cmax) and Area Under the Curve (AUC).
Lithium: Co-administration has been officially associated in some patients with the development of an encephalopathic syndrome, a form of neurological toxicity.
Metabolic Pathway: Prochlorperazine is primarily metabolized via the CYP2D6 enzyme system.
Antagonism: The medicine may officially antagonize the therapeutic effects of Levodopa.

Mechanism of Action

How Stemetil MD Works

Stemetil MD, which contains prochlorperazine, exerts its primary action within the central nervous system as a dopamine (D2) receptor antagonist. This mechanism involves the molecule binding to and occupying D2 receptor sites, thereby preventing the natural neurotransmitter, dopamine, from activating the receptor.

Blocking Signals in the Chemoreceptor Trigger Zone (CTZ)

The principal site of action is the Chemoreceptor Trigger Zone (CTZ), a specialized brain region that monitors blood for emetic substances. Antagonism of the D2 receptors in the CTZ interferes with the molecular signaling cascade, resulting in the suppression of the initiation of the emetic reflex. This action reduces the transmission of signals that originate from systemic triggers on the central control centers.

Modulation of Inner Ear and Balance Pathways

The mechanism also extends to influencing the vestibular pathway, which relays signals regarding balance and motion from the inner ear. This action results in the dampening of overactive signaling within these pathways and contributes to altered signaling dynamics of spatial processing. This modifies the processing of motion-related input signals at the physiological level.

Dosage and Administration Information

How to Use Stemetil MD: Administration Guidelines

Stemetil MD (Prochlorperazine) is a mouth-dissolving tablet taken by the oral route. These guidelines reflect the instructions for use, focusing strictly on administration procedures.

Administration Steps

Procedural Step	Instruction Detail
Method	Place the tablet on the tongue and allow it to dissolve completely. Do not swallow whole, crush, chew, or break it.
Timing	The medicine can be taken before or after food; its absorption is not restricted by mealtimes.
Discontinuation	Do not stop taking the medicine suddenly or reduce the dosage without consulting a healthcare provider.

Dosing Schedule

The dosage must be determined by a healthcare provider and adjusted to suit the individual, typically starting at the lowest effective amount.

Patient Group	Recommended Dosing Range (Typical)
Adults	Usual dose is 5 mg or 10 mg, taken two or three times daily. The daily maximum is 40 mg.
Children (2+ years)	Dosing is weight-based (e.g., 2.5 mg two or three times a day) with specific maximum limits that must not be exceeded. Use is not recommended for children under 2 years old or under 9–10 kg.
Elderly	Treatment should generally begin with the lower end of the dosing range, and any increase should be more gradual than for younger adults.

Managing Missed Doses

If you miss a dose, take it as soon as you remember. If it is almost time for the next scheduled dose, skip the missed dose entirely and return to your regular dosing schedule. Do not take a double dose to compensate for the one you missed.

Recent Clinical Evidence

Research Evidence: Overview of Studies

Research on Biological Activity

Prochlorperazine, the active component of Stemetil MD, is generally classified as a dopamine receptor antagonist. Research explores the drug's activity in relation to D2 dopamine receptors in the chemoreceptor trigger zone (CTZ), which is a major area involved in regulating nausea and vomiting signals.

Clinical Trial Outcomes

Recent studies have focused on the profile of prochlorperazine in the management of specific conditions like acute vertigo, nausea, and vomiting.

Acute Vertigo: Multiple observational and post-marketing studies have measured outcomes in patients experiencing acute vertigo. In one large prospective study, over 90% of participants demonstrated an improvement in clinical response related to vertigo severity by Day 6. Secondary outcomes included measured changes in associated symptoms like nausea and vomiting.
Nausea and Vomiting (N/V): Randomized controlled trials (RCTs) have assessed the measured relief from N/V in emergency department settings, with some trials reporting that prochlorperazine showed more rapid and complete outcomes compared to another commonly used antiemetic.

Tolerability Profile

Long-term safety data documented the incidence of adverse events in the studied populations. Common adverse events reported in trials included drowsiness, dry mouth, and mild headache. Studies on certain populations, such as elderly patients, often included close monitoring due to known risks associated with this class of medication, including the potential for extrapyramidal symptoms (EPS). The overall discontinuation rate due to adverse events was low across various follow-up periods in many non-comparative trials.

Frequently Asked Questions (FAQ)

Common questions about Stemetil MD (FAQ)

Q: Is Stemetil MD the same as other anti-sickness tablets?

According to the official product information, Stemetil MD contains the active ingredient prochlorperazine, a medicine belonging to the phenothiazine class. Its primary action involves blocking specific dopamine D2 receptors in the brain to control nausea. This mechanism is considered distinct from that of some other anti-sickness medicines, such as those that primarily affect histamine pathways.

Q: Is Stemetil MD safe to use for a long period?

Regulatory guidelines note that the use of this medicine is typically recommended for short periods, for example, less than one week when treating acute vertigo. Official warnings indicate that prolonged exposure carries an increased risk of serious adverse effects, including a condition called tardive dyskinesia, which involves involuntary movements.

Q: Can Stemetil MD cause withdrawal symptoms if stopped suddenly?

Regulatory documents advise against suddenly stopping the medicine, especially after long-term use. Abrupt discontinuation may result in transient neurological signs, such as involuntary movements.

Q: What happens if Stemetil MD is taken with certain antidepressants?

Taking this medicine with certain types of antidepressants may increase the risk of specific side effects. This combination may intensify drowsiness, or potentially affect the heart's electrical rhythm, known as QTc interval changes. Official guidance emphasizes the importance of a patient discussing all current medications with a healthcare provider.

Q: What type of vertigo or dizziness does Stemetil MD treat best?

Official product indications specify that prochlorperazine is used for the management of vertigo caused by specific inner ear conditions. These approved uses are described as including symptoms related to Ménière's syndrome and labyrinthitis.

Q: Can Stemetil MD make you feel jittery or restless?

Official documentation lists restlessness as a known but less common side effect. This feeling is associated with a group of potential central nervous system effects described in the product information.

Q: What's the difference between Stemetil MD and other forms of prochlorperazine?

The 'MD' in Stemetil MD signifies Mouth Dissolving. This means the tablet is designed to be placed on the tongue where it dissolves promptly. This design distinguishes it from standard tablets, which are swallowed whole, as well as injectable solutions or suppositories.

Q: What is the standard regulatory approval for Stemetil MD?

Prochlorperazine is defined in official regulatory documents as being approved for controlling severe nausea and vomiting. It is also approved for the short-term treatment of certain psychotic disorders.

Q: What kind of studies have been done on Stemetil MD and long-term safety?

Studies related to the long-term safety profile typically focus on the incidence of adverse events, particularly the increased risk of tardive dyskinesia with prolonged exposure. Official guidelines describe the need for periodic monitoring of blood and liver function for patients on maintenance therapy.

Q: What should I watch out for when taking Stemetil MD for the first time?

Official advice describes what patients may experience initially, such as common effects like drowsiness or dizziness. Additionally, signs of acute extrapyramidal symptoms, which affect movement, can sometimes be observed early in the course of treatment.

Q: Does Stemetil MD help with headaches that come with nausea?

Official indications for prochlorperazine include the treatment of severe nausea and vomiting. This covers the intense nausea associated with conditions like migraine.

Q: Is Stemetil MD used for travel sickness?

Official drug documents state that prochlorperazine is indicated for treating nausea and vomiting. This includes the specific symptoms associated with motion sickness, which is often referred to as travel sickness.

Q: How quickly does Stemetil MD start working?

The onset of action for the anti-sickness effect is documented in official sources as typically occurring within 30 to 60 minutes. This is based on studies of oral administration.

Q: Can Stemetil MD be taken for anxiety or panic attacks?

Official drug information for prochlorperazine may include its approved use for the short-term management of certain anxiety states. This use is generally reserved for anxiety that has not responded adequately to other treatments.

Q: Can Stemetil MD affect my ability to drive?

Official regulatory warnings describe the need for caution regarding driving or operating heavy machinery. This is due to the potential for side effects like drowsiness or dizziness, which can impair motor skills and judgment.

Q: Is it normal to feel dizzy after taking Stemetil MD?

Dizziness is listed in the official documentation as a common side effect of prochlorperazine. This effect is sometimes linked to postural hypotension, which is a drop in blood pressure when standing up.

Q: Is Stemetil MD available over the counter in some countries?

Prochlorperazine is consistently classified across global regulatory documents and patient information as a prescription-only medicine.

Q: How long does the effect of Stemetil MD usually last?

The anti-sickness effect of prochlorperazine is documented to be variable based on the dose and administration route. The duration of effect is generally stated in official sources as lasting approximately three to four hours.

Q: Is Stemetil MD a controlled substance?

Official government drug classification documents state that prochlorperazine is not classified as a controlled substance.

Q: Does Stemetil MD have a reputation for being addictive?

Official patient warnings and regulatory documents do not indicate that prochlorperazine has addictive properties or the potential to cause physical dependence.

Q: What is the typical duration of treatment with Stemetil MD?

The typical duration of treatment is short, with official guidelines recommending limited use. For example, treatment for acute vertigo is typically limited to less than one week.

Q: Does Stemetil MD interact with common herbal supplements?

Official guidance states that patients should inform a healthcare provider about all herbal remedies or supplements they are taking. This is due to a general lack of specific safety and interaction testing data for herbal products when combined with the medicine.

Q: Is Stemetil MD effective for general queasiness or motion sickness?

Regulatory indications state that prochlorperazine is used for the treatment of nausea and vomiting, which includes symptoms caused by motion sickness.

Q: Is there a maximum amount of time I can safely use Stemetil MD?

Due to the increased risk of serious adverse effects, such as tardive dyskinesia, with prolonged exposure, the use of this medicine is generally recommended for short periods only.

Q: Does Stemetil MD interact with medications for high blood sugar?

Official interaction data indicates that prochlorperazine may affect blood glucose control. This effect can potentially reduce the effectiveness of certain antidiabetic medicines, which is why close monitoring is typically advised by healthcare professionals.

Q: Are there alternatives to Stemetil MD for dizziness?

Official formularies and treatment guidelines list several alternative medicines for symptoms of vertigo and dizziness. These may include antihistamine-based medicines like cyclizine or cinnarizine, or betahistine for specific conditions.

Q: What is the shelf life of Stemetil MD?

Official storage guidelines advise patients to check the expiration date printed on the packaging. Expired medicine should be handled according to local pharmaceutical disposal regulations.

How should Stemetil MD be stored and disposed of?

Storage and Disposal of Stemetil MD

Stemetil MD (prochlorperazine maleate) must be stored under specific conditions to maintain its effectiveness. Regulatory documents require storage at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The medicine must be protected from light and moisture and kept in a tight, light-resistant container. Always keep the product out of the sight and reach of children.

For disposal, do not dispose of Stemetil MD in household waste or wastewater. Unused or expired medication must be handled in accordance with local pharmaceutical regulations. Consult a pharmacist for guidance on proper disposal.

Stemetil MD